IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine-Reference-Cited by-同舟云学术

IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine

Published:2019-04 Issue:17 Volume:37 Page:2322-2330
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sarkar Sanghita,Piepenbrink Michael S.,Basu Madhubanti,Thakar Juilee,Keefer Michael C.,Hessell Ann J.,Haigwood Nancy L.^ORCID,Kobie James J.

Funder

National Institutes of Health

University of Rochester Center

University of Rochester

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference69 articles.

1. Joint United Nations Programme on HIV/AIDS. Miles to go. Global AIDS update 2018. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2018. http://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf.

2. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities;Kharsany;Open AIDS J,2016

3. A blueprint for HIV vaccine discovery;Burton;Cell Host Microbe,2012

4. Rational HIV immunogen design to target specific germline B cell receptors;Jardine;Science,2013

5. Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies;Malherbe;J Virol,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19;Frontiers in Immunology;2022-04-05

2. HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model;Frontiers in Immunology;2021-11-02

3. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals;Nature Communications;2021-04-09

4. Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature;Scientific Reports;2021-02-10

5. COVID-19-neutralizing antibodies predict disease severity and survival;Cell;2021-01